Christopher P. Denton

Research interests

Publications

• Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis

  Autoimmunity Reviews · 2020 · https://doi.org/10.1016/j.autrev.2020.102458

• Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

  The Lancet Respiratory Medicine · 2020 · https://doi.org/10.1016/s2213-2600(20)30318-0

• Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

  The Lancet Respiratory Medicine · 2020 · https://doi.org/10.1016/s2213-2600(20)30318-0

• Systemic sclerosis

  The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)30933-9

• European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes

  Journal of the European Academy of Dermatology and Venereology · 2017 · https://doi.org/10.1111/jdv.14458

• Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)

  Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2017-211682

• Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

  The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)00232-4

• Update of EULAR recommendations for the treatment of systemic sclerosis

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209909

• The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209768

• 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

  Annals of the Rheumatic Diseases · 2013 · https://doi.org/10.1136/annrheumdis-2013-204424

• 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

  Arthritis & Rheumatism · 2013 · https://doi.org/10.1002/art.38098

• Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

  Annals of the Rheumatic Diseases · 2013 · https://doi.org/10.1136/annrheumdis-2013-203301

• Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis

  Annals of the Rheumatic Diseases · 2013 · https://doi.org/10.1136/annrheumdis-2013-203716

• Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

  Annals of the Rheumatic Diseases · 2012 · https://doi.org/10.1136/annrheumdis-2011-200742

• Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

  Annals of the Rheumatic Diseases · 2010 · https://doi.org/10.1136/ard.2009.114264

• Interstitial Lung Disease in Systemic Sclerosis

  American Journal of Respiratory and Critical Care Medicine · 2008 · https://doi.org/10.1164/rccm.200706-877oc

• Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

  Annals of the Rheumatic Diseases · 2007 · https://doi.org/10.1136/ard.2006.062901

• Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo‐controlled phase I/II trial of CAT‐192

  Arthritis & Rheumatism · 2006 · https://doi.org/10.1002/art.22289

• A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

  Arthritis & Rheumatism · 2006 · https://doi.org/10.1002/art.22204

Current projects

No projects listed.